MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 364 filers reported holding MEDIVATION INC in Q1 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $282,000 | +68.9% | 4,678 | +28.5% | 0.03% | +55.0% |
| Q1 2016 | $167,000 | -44.9% | 3,640 | -42.0% | 0.02% | -48.7% |
| Q4 2015 | $303,000 | +10.6% | 6,276 | -2.6% | 0.04% | +5.4% |
| Q3 2015 | $274,000 | -41.9% | 6,444 | +56.0% | 0.04% | -36.2% |
| Q2 2015 | $472,000 | +60.5% | 4,130 | +81.3% | 0.06% | +56.8% |
| Q1 2015 | $294,000 | +101.4% | 2,278 | +55.3% | 0.04% | +94.7% |
| Q4 2014 | $146,000 | – | 1,467 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |